The company is working on expanding its flagship LiverMultiScan product, a tool used to diagnose and assess liver disease.
The second tranche of series C funding brings the company’s total series C round to $55 million, according to a March 15 Perspectum news release.
Since the company’s inception, it has raised $140 million. Oppenheimer led the latest series C investment round.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.